Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New anticonvulsants.

F J Vajda1

  • 1Department of Neurology, Austin Hospital, University of Melbourne, Heidelberg, Victoria, Australia.

Current Opinion in Neurology and Neurosurgery
|August 1, 1992
PubMed
Summary
This summary is machine-generated.

New antiepileptic drugs show promise, but regulatory hurdles slow development. Vigabatrin, lamotrigine, and gabapentin are leading candidates, with loreclezole and stiripentol also demonstrating potential therapeutic benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective study of local cutaneous reactions in patients receiving IV phenytoin.

Neurology·2001
Same author

Epilepsy, depression and antidepressant drugs.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2001
Same author

Contemporary management of epilepsy in pregnancy.

The Australian & New Zealand journal of obstetrics & gynaecology·2001
Same author

New antiepileptic drugs.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2000
Same author

Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.

Clinical and experimental rheumatology·1999
Same author

Determination of lamotrigine in human plasma by high-performance liquid chromatography.

Journal of chromatography. B, Biomedical sciences and applications·1999
Same journal

Neuropharmacology.

Current opinion in neurology and neurosurgery·1993
Same journal

Disorders of the spinal cord and cauda equina.

Current opinion in neurology and neurosurgery·1993
Same journal

Autonomic disorders.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular and cell biology of addiction.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular mechanisms of trauma-induced neuronal degeneration.

Current opinion in neurology and neurosurgery·1993
Same journal

Excitatory amino acid receptors and epilepsy.

Current opinion in neurology and neurosurgery·1993
See all related articles

Area of Science:

  • Pharmacology
  • Clinical Neurology
  • Drug Development

Background:

  • Antiepileptic drug (AED) development faces slow progress, partly due to stringent regulatory requirements for demonstrating superior efficacy over existing treatments.
  • Revising clinical trial protocols is crucial for effectively evaluating new AEDs.

Purpose of the Study:

  • To review the progress and potential of newly developed antiepileptic drugs.
  • To identify promising AED candidates and assess their therapeutic potential.

Main Methods:

  • Review of clinical trial data for recently developed antiepileptic drugs.
  • Comparative analysis of efficacy and safety profiles of new AEDs.

Main Results:

  • Vigabatrin (GVG), lamotrigine (LTG), gabapentin (GPT), felbamate, and oxcarbazepine (OCBZ) are identified as the most extensively tested and promising AEDs.

Related Experiment Videos

  • Loreclezole and stiripentol (STP) exhibit significant potential for clinical application.
  • Clobazam demonstrates greater efficacy than previously reported.

    • Conclusions:

    • Several new antiepileptic drugs show considerable therapeutic promise.
    • Further research and optimized trial designs are needed to facilitate the approval of effective new AEDs.